Share Price and Basic Stock Data
Last Updated: January 23, 2026, 9:02 pm
| PEG Ratio | -0.53 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Manali Petrochemicals Ltd operates in the petrochemicals sector, focusing on polymer production. The company reported a market capitalization of ₹946 Cr and a share price of ₹55.3. Over the last fiscal year, the company’s sales stood at ₹1,177 Cr, a decline from ₹1,672 Cr in FY 2022. Quarterly sales figures showed fluctuations, with the highest recorded in March 2023 at ₹334 Cr and a recent decline to ₹270 Cr by September 2023. The trailing twelve-month (TTM) sales figure is ₹909 Cr, indicating a downward trend compared to previous years. The company’s operational performance is reflected in the operating profit margin (OPM), which recorded a low of 2% in March 2023, but improved to 5% by September 2023. This volatility in sales and profitability underscores the challenges faced in a competitive environment, as well as the need for strategic adjustments to stabilize revenue streams.
Profitability and Efficiency Metrics
Manali Petrochemicals demonstrated mixed profitability metrics in recent periods. The return on equity (ROE) stood at 2.92%, while the return on capital employed (ROCE) was reported at 4.66%, both indicating low efficiency relative to industry standards. The company recorded a net profit of ₹49 Cr for the TTM period, which is considerably lower than the peak profit of ₹381 Cr in FY 2022. Operating profit margins have fluctuated, with a notable rise to 10% in June 2025, yet the overall profitability remains constrained. The interest coverage ratio (ICR) at 7.92x signifies a comfortable buffer against interest payments, although the net profit margin of 3.26% reflects ongoing cost pressures. The cash conversion cycle (CCC) extended to 108 days in FY 2025, raising concerns regarding liquidity and operational efficiency, as industry norms often favor shorter cycles.
Balance Sheet Strength and Financial Ratios
The balance sheet of Manali Petrochemicals reflects a cautious financial strategy, with total borrowings reported at ₹155 Cr against reserves of ₹1,056 Cr. The debt-to-equity ratio stood at 0.04, indicating a low leverage position, which is favorable in terms of financial stability. However, the trailing twelve-month (TTM) book value per share increased to ₹63.61, suggesting a gradual build-up of shareholder equity. The company’s current ratio of 3.31x indicates robust liquidity, allowing it to meet short-term obligations comfortably. Despite these strengths, the return on assets (ROA) at 2.08% and the price-to-book value (P/BV) ratio of 0.88x suggest that the stock may be undervalued relative to its net assets. This valuation metric signals potential for price appreciation if operational efficiency improves and profitability stabilizes.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Manali Petrochemicals shows a stable ownership structure, with promoters holding 44.87% of the equity. The public holds a significant 54.69%, while foreign institutional investors (FIIs) have a minimal stake of 0.44%. There has been a decline in FII participation from 1.95% in December 2022 to 0.44% in September 2025, indicating reduced foreign interest in the company. Domestic institutional investors (DIIs) remain negligible at 0.01%. The total number of shareholders has decreased from 2,00,631 in December 2022 to 1,57,079 by September 2025, reflecting a possible lack of confidence among retail investors. This decline in both institutional and retail participation can pose risks to future capital raising efforts and may influence market perceptions of the company’s growth potential.
Outlook, Risks, and Final Insight
The outlook for Manali Petrochemicals hinges on its ability to navigate operational challenges and enhance profitability. Key strengths include a low debt position, strong liquidity ratios, and a stable promoter holding, which provide a solid foundation for future growth. However, risks such as declining sales momentum, low profitability margins, and a shrinking investor base could hinder recovery efforts. The company must focus on improving operational efficiency and possibly diversifying its product range to capture new market segments. If the management successfully implements strategic initiatives to optimize costs and boost sales, there could be a turnaround in performance. Conversely, persistent market pressures and operational inefficiencies may lead to further declines in profitability and investor sentiment. The need for a proactive approach to enhance shareholder value is critical in the current competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Fluoro Carbons Ltd | 32.9 Cr. | 16.8 | 19.6/10.8 | 274 | 41.8 | 0.00 % | 1.02 % | % | 10.0 |
| Gujarat Petrosynthese Ltd | 34.6 Cr. | 58.0 | 81.5/51.5 | 17.8 | 85.2 | 0.00 % | 4.45 % | 2.93 % | 10.0 |
| AVI Polymers Ltd | 6.86 Cr. | 16.8 | 34.6/9.89 | 2.25 | 19.5 | 0.00 % | 19.4 % | 15.6 % | 10.0 |
| Supreme Petrochem Ltd | 9,429 Cr. | 501 | 982/461 | 34.7 | 118 | 1.99 % | 22.8 % | 17.4 % | 2.00 |
| Signet Industries Ltd | 141 Cr. | 47.7 | 81.8/39.0 | 6.90 | 80.3 | 1.05 % | 13.7 % | 6.88 % | 10.0 |
| Industry Average | 2,997.71 Cr | 141.94 | 50.21 | 83.12 | 1.03% | 14.57% | 13.10% | 7.55 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 286 | 238 | 334 | 301 | 270 | 205 | 256 | 240 | 230 | 196 | 230 | 235 | 248 |
| Expenses | 268 | 234 | 327 | 294 | 255 | 200 | 239 | 220 | 226 | 183 | 209 | 212 | 228 |
| Operating Profit | 18 | 4 | 6 | 8 | 15 | 5 | 17 | 21 | 4 | 13 | 21 | 23 | 20 |
| OPM % | 6% | 2% | 2% | 3% | 5% | 3% | 7% | 9% | 2% | 6% | 9% | 10% | 8% |
| Other Income | 6 | 6 | 5 | 7 | 9 | 8 | 1 | 6 | 6 | 4 | 5 | 8 | 12 |
| Interest | 2 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 3 | 3 |
| Depreciation | 6 | 6 | 7 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 8 |
| Profit before tax | 17 | 2 | 2 | 6 | 15 | 5 | 8 | 18 | 1 | 8 | 16 | 20 | 21 |
| Tax % | 30% | -89% | 119% | 30% | 27% | 35% | 84% | 27% | 64% | 31% | 32% | 28% | 14% |
| Net Profit | 12 | 3 | -0 | 4 | 11 | 3 | 1 | 13 | 0 | 5 | 11 | 14 | 18 |
| EPS in Rs | 0.68 | 0.18 | -0.03 | 0.24 | 0.63 | 0.17 | 0.08 | 0.76 | 0.01 | 0.31 | 0.63 | 0.83 | 1.06 |
Last Updated: December 30, 2025, 1:37 am
Below is a detailed analysis of the quarterly data for Manali Petrochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 248.00 Cr.. The value appears strong and on an upward trend. It has increased from 235.00 Cr. (Jun 2025) to 248.00 Cr., marking an increase of 13.00 Cr..
- For Expenses, as of Sep 2025, the value is 228.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 212.00 Cr. (Jun 2025) to 228.00 Cr., marking an increase of 16.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Jun 2025) to 20.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Sep 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Jun 2025) to 8.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Jun 2025) to 12.00 Cr., marking an increase of 4.00 Cr..
- For Interest, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 8.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Jun 2025) to 21.00 Cr., marking an increase of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 14.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Jun 2025) to 14.00%, marking a decrease of 14.00%.
- For Net Profit, as of Sep 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Jun 2025) to 18.00 Cr., marking an increase of 4.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.06. The value appears strong and on an upward trend. It has increased from 0.83 (Jun 2025) to 1.06, marking an increase of 0.23.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:00 am
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 579 | 626 | 748 | 810 | 803 | 1,024 | 1,672 | 1,177 | 1,032 | 897 | 909 |
| Expenses | 511 | 574 | 651 | 710 | 733 | 723 | 1,143 | 1,103 | 985 | 839 | 832 |
| Operating Profit | 68 | 52 | 97 | 100 | 70 | 302 | 529 | 74 | 47 | 58 | 77 |
| OPM % | 12% | 8% | 13% | 12% | 9% | 29% | 32% | 6% | 5% | 7% | 8% |
| Other Income | 9 | 18 | 3 | 27 | 5 | -8 | 11 | 28 | 21 | 21 | 29 |
| Interest | 3 | 2 | 3 | 2 | 6 | 5 | 9 | 9 | 10 | 10 | 12 |
| Depreciation | 6 | 8 | 9 | 11 | 14 | 21 | 20 | 23 | 25 | 27 | 29 |
| Profit before tax | 69 | 60 | 88 | 113 | 54 | 268 | 511 | 70 | 33 | 42 | 65 |
| Tax % | 31% | 37% | 34% | 33% | 14% | 25% | 25% | 28% | 42% | 30% | |
| Net Profit | 48 | 38 | 58 | 77 | 47 | 201 | 381 | 51 | 19 | 29 | 49 |
| EPS in Rs | 2.79 | 2.20 | 3.37 | 4.45 | 2.71 | 11.70 | 22.16 | 2.95 | 1.12 | 1.70 | 2.83 |
| Dividend Payout % | 18% | 23% | 15% | 17% | 28% | 13% | 11% | 25% | 67% | 29% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -20.83% | 52.63% | 32.76% | -38.96% | 327.66% | 89.55% | -86.61% | -62.75% | 52.63% |
| Change in YoY Net Profit Growth (%) | 0.00% | 73.46% | -19.87% | -71.72% | 366.62% | -238.11% | -176.17% | 23.87% | 115.38% |
Manali Petrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: December 4, 2025, 1:37 am
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 86 | 86 | 86 | 86 | 86 | 86 | 86 | 86 | 86 | 86 | 86 |
| Reserves | 196 | 225 | 306 | 369 | 395 | 594 | 944 | 958 | 976 | 1,008 | 1,056 |
| Borrowings | 2 | 26 | 23 | 34 | 26 | 14 | 19 | 7 | 103 | 129 | 155 |
| Other Liabilities | 215 | 195 | 141 | 165 | 153 | 198 | 241 | 223 | 144 | 179 | 175 |
| Total Liabilities | 499 | 532 | 556 | 654 | 660 | 892 | 1,290 | 1,274 | 1,308 | 1,403 | 1,472 |
| Fixed Assets | 105 | 206 | 273 | 283 | 302 | 292 | 343 | 552 | 559 | 596 | 600 |
| CWIP | 16 | 28 | 12 | 6 | 26 | 28 | 14 | 23 | 17 | 61 | 98 |
| Investments | 69 | 16 | 57 | 0 | 41 | 0 | 0 | 0 | 29 | 15 | 6 |
| Other Assets | 310 | 282 | 214 | 364 | 291 | 572 | 933 | 700 | 704 | 731 | 767 |
| Total Assets | 499 | 532 | 556 | 654 | 660 | 892 | 1,290 | 1,274 | 1,308 | 1,403 | 1,472 |
Below is a detailed analysis of the balance sheet data for Manali Petrochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 86.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 86.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,056.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,008.00 Cr. (Mar 2025) to 1,056.00 Cr., marking an increase of 48.00 Cr..
- For Borrowings, as of Sep 2025, the value is 155.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 129.00 Cr. (Mar 2025) to 155.00 Cr., marking an increase of 26.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 175.00 Cr.. The value appears to be improving (decreasing). It has decreased from 179.00 Cr. (Mar 2025) to 175.00 Cr., marking a decrease of 4.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,472.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,403.00 Cr. (Mar 2025) to 1,472.00 Cr., marking an increase of 69.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 600.00 Cr.. The value appears strong and on an upward trend. It has increased from 596.00 Cr. (Mar 2025) to 600.00 Cr., marking an increase of 4.00 Cr..
- For CWIP, as of Sep 2025, the value is 98.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 98.00 Cr., marking an increase of 37.00 Cr..
- For Investments, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 9.00 Cr..
- For Other Assets, as of Sep 2025, the value is 767.00 Cr.. The value appears strong and on an upward trend. It has increased from 731.00 Cr. (Mar 2025) to 767.00 Cr., marking an increase of 36.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,472.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,403.00 Cr. (Mar 2025) to 1,472.00 Cr., marking an increase of 69.00 Cr..
Notably, the Reserves (1,056.00 Cr.) exceed the Borrowings (155.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 66.00 | 26.00 | 74.00 | 66.00 | 44.00 | 288.00 | 510.00 | 67.00 | -56.00 | -71.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 57 | 48 | 49 | 51 | 49 | 61 | 35 | 49 | 43 | 48 |
| Inventory Days | 96 | 101 | 53 | 81 | 58 | 47 | 35 | 47 | 55 | 123 |
| Days Payable | 124 | 109 | 47 | 64 | 36 | 54 | 38 | 27 | 31 | 62 |
| Cash Conversion Cycle | 29 | 39 | 55 | 68 | 71 | 54 | 32 | 70 | 67 | 108 |
| Working Capital Days | 43 | 16 | 21 | 50 | 38 | 33 | 23 | 44 | 32 | 61 |
| ROCE % | 20% | 24% | 22% | 14% | 49% | 60% | 8% | 5% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 1.70 | 1.12 | 2.95 | 22.16 | 11.70 |
| Diluted EPS (Rs.) | 1.70 | 1.12 | 2.95 | 22.16 | 11.70 |
| Cash EPS (Rs.) | 3.28 | 2.59 | 4.29 | 23.31 | 12.92 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 63.61 | 61.73 | 60.70 | 59.88 | 39.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 63.61 | 61.73 | 60.70 | 59.88 | 39.52 |
| Revenue From Operations / Share (Rs.) | 52.14 | 60.02 | 68.66 | 97.17 | 59.25 |
| PBDIT / Share (Rs.) | 4.81 | 4.29 | 5.95 | 31.77 | 18.27 |
| PBIT / Share (Rs.) | 3.24 | 2.82 | 4.60 | 30.60 | 17.05 |
| PBT / Share (Rs.) | 2.44 | 1.94 | 4.07 | 29.67 | 15.57 |
| Net Profit / Share (Rs.) | 1.70 | 1.12 | 2.94 | 22.15 | 11.69 |
| NP After MI And SOA / Share (Rs.) | 1.70 | 1.12 | 2.94 | 22.15 | 11.69 |
| PBDIT Margin (%) | 9.22 | 7.14 | 8.66 | 32.69 | 30.82 |
| PBIT Margin (%) | 6.20 | 4.69 | 6.70 | 31.49 | 28.76 |
| PBT Margin (%) | 4.68 | 3.23 | 5.92 | 30.53 | 26.27 |
| Net Profit Margin (%) | 3.26 | 1.86 | 4.28 | 22.79 | 19.73 |
| NP After MI And SOA Margin (%) | 3.26 | 1.86 | 4.28 | 22.79 | 19.73 |
| Return on Networth / Equity (%) | 2.67 | 1.80 | 4.85 | 36.98 | 29.59 |
| Return on Capital Employeed (%) | 4.66 | 4.23 | 7.02 | 47.62 | 40.58 |
| Return On Assets (%) | 2.08 | 1.46 | 3.97 | 29.53 | 22.69 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.04 | 0.02 | 0.01 | 0.01 | 0.02 |
| Asset Turnover Ratio (%) | 0.66 | 0.79 | 0.92 | 1.38 | 1.24 |
| Current Ratio (X) | 3.31 | 4.31 | 4.58 | 4.92 | 3.36 |
| Quick Ratio (X) | 2.38 | 3.64 | 3.84 | 4.44 | 2.93 |
| Inventory Turnover Ratio (X) | 5.90 | 6.65 | 8.86 | 10.51 | 6.51 |
| Dividend Payout Ratio (NP) (%) | 44.04 | 67.20 | 84.88 | 6.77 | 6.41 |
| Dividend Payout Ratio (CP) (%) | 22.89 | 28.99 | 58.24 | 6.43 | 5.80 |
| Earning Retention Ratio (%) | 55.96 | 32.80 | 15.12 | 93.23 | 93.59 |
| Cash Earning Retention Ratio (%) | 77.11 | 71.01 | 41.76 | 93.57 | 94.20 |
| Interest Coverage Ratio (X) | 7.92 | 7.69 | 11.10 | 58.69 | 66.80 |
| Interest Coverage Ratio (Post Tax) (X) | 4.11 | 3.58 | 6.50 | 42.63 | 48.18 |
| Enterprise Value (Cr.) | 679.26 | 566.51 | 656.34 | 1266.42 | 747.69 |
| EV / Net Operating Revenue (X) | 0.75 | 0.54 | 0.55 | 0.75 | 0.73 |
| EV / EBITDA (X) | 8.20 | 7.68 | 6.41 | 2.32 | 2.38 |
| MarketCap / Net Operating Revenue (X) | 1.08 | 0.93 | 0.87 | 1.12 | 1.00 |
| Retention Ratios (%) | 55.95 | 32.79 | 15.11 | 93.22 | 93.58 |
| Price / BV (X) | 0.88 | 0.91 | 0.99 | 1.81 | 1.50 |
| Price / Net Operating Revenue (X) | 1.08 | 0.93 | 0.87 | 1.12 | 1.00 |
| EarningsYield | 0.03 | 0.01 | 0.04 | 0.20 | 0.19 |
After reviewing the key financial ratios for Manali Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.70. This value is below the healthy minimum of 5. It has increased from 1.12 (Mar 24) to 1.70, marking an increase of 0.58.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.70. This value is below the healthy minimum of 5. It has increased from 1.12 (Mar 24) to 1.70, marking an increase of 0.58.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.28. This value is within the healthy range. It has increased from 2.59 (Mar 24) to 3.28, marking an increase of 0.69.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.61. It has increased from 61.73 (Mar 24) to 63.61, marking an increase of 1.88.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.61. It has increased from 61.73 (Mar 24) to 63.61, marking an increase of 1.88.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 52.14. It has decreased from 60.02 (Mar 24) to 52.14, marking a decrease of 7.88.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 4.81. This value is within the healthy range. It has increased from 4.29 (Mar 24) to 4.81, marking an increase of 0.52.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.24. This value is within the healthy range. It has increased from 2.82 (Mar 24) to 3.24, marking an increase of 0.42.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.44. This value is within the healthy range. It has increased from 1.94 (Mar 24) to 2.44, marking an increase of 0.50.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.70. This value is below the healthy minimum of 2. It has increased from 1.12 (Mar 24) to 1.70, marking an increase of 0.58.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.70. This value is below the healthy minimum of 2. It has increased from 1.12 (Mar 24) to 1.70, marking an increase of 0.58.
- For PBDIT Margin (%), as of Mar 25, the value is 9.22. This value is below the healthy minimum of 10. It has increased from 7.14 (Mar 24) to 9.22, marking an increase of 2.08.
- For PBIT Margin (%), as of Mar 25, the value is 6.20. This value is below the healthy minimum of 10. It has increased from 4.69 (Mar 24) to 6.20, marking an increase of 1.51.
- For PBT Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 10. It has increased from 3.23 (Mar 24) to 4.68, marking an increase of 1.45.
- For Net Profit Margin (%), as of Mar 25, the value is 3.26. This value is below the healthy minimum of 5. It has increased from 1.86 (Mar 24) to 3.26, marking an increase of 1.40.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.26. This value is below the healthy minimum of 8. It has increased from 1.86 (Mar 24) to 3.26, marking an increase of 1.40.
- For Return on Networth / Equity (%), as of Mar 25, the value is 2.67. This value is below the healthy minimum of 15. It has increased from 1.80 (Mar 24) to 2.67, marking an increase of 0.87.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.66. This value is below the healthy minimum of 10. It has increased from 4.23 (Mar 24) to 4.66, marking an increase of 0.43.
- For Return On Assets (%), as of Mar 25, the value is 2.08. This value is below the healthy minimum of 5. It has increased from 1.46 (Mar 24) to 2.08, marking an increase of 0.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.66. It has decreased from 0.79 (Mar 24) to 0.66, marking a decrease of 0.13.
- For Current Ratio (X), as of Mar 25, the value is 3.31. This value exceeds the healthy maximum of 3. It has decreased from 4.31 (Mar 24) to 3.31, marking a decrease of 1.00.
- For Quick Ratio (X), as of Mar 25, the value is 2.38. This value exceeds the healthy maximum of 2. It has decreased from 3.64 (Mar 24) to 2.38, marking a decrease of 1.26.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.90. This value is within the healthy range. It has decreased from 6.65 (Mar 24) to 5.90, marking a decrease of 0.75.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 44.04. This value is within the healthy range. It has decreased from 67.20 (Mar 24) to 44.04, marking a decrease of 23.16.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 22.89. This value is within the healthy range. It has decreased from 28.99 (Mar 24) to 22.89, marking a decrease of 6.10.
- For Earning Retention Ratio (%), as of Mar 25, the value is 55.96. This value is within the healthy range. It has increased from 32.80 (Mar 24) to 55.96, marking an increase of 23.16.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 77.11. This value exceeds the healthy maximum of 70. It has increased from 71.01 (Mar 24) to 77.11, marking an increase of 6.10.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.92. This value is within the healthy range. It has increased from 7.69 (Mar 24) to 7.92, marking an increase of 0.23.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.11. This value is within the healthy range. It has increased from 3.58 (Mar 24) to 4.11, marking an increase of 0.53.
- For Enterprise Value (Cr.), as of Mar 25, the value is 679.26. It has increased from 566.51 (Mar 24) to 679.26, marking an increase of 112.75.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.75, marking an increase of 0.21.
- For EV / EBITDA (X), as of Mar 25, the value is 8.20. This value is within the healthy range. It has increased from 7.68 (Mar 24) to 8.20, marking an increase of 0.52.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.93 (Mar 24) to 1.08, marking an increase of 0.15.
- For Retention Ratios (%), as of Mar 25, the value is 55.95. This value is within the healthy range. It has increased from 32.79 (Mar 24) to 55.95, marking an increase of 23.16.
- For Price / BV (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 24) to 0.88, marking a decrease of 0.03.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.93 (Mar 24) to 1.08, marking an increase of 0.15.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.03, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Manali Petrochemicals Ltd:
- Net Profit Margin: 3.26%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.66% (Industry Average ROCE: 14.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.67% (Industry Average ROE: 13.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.11
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.38
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.8 (Industry average Stock P/E: 50.21)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.04
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.26%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Petrochemicals - Polymers | SPIC HOUSE, Chennai (Madras) Tamil Nadu 600032 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashwin C Muthiah | Chairman |
| Mr. R Chandrasekar | Managing Director & CEO |
| Mr. G R Sridhar | Whole Time Director |
| Lt. Col. (Retd). Chatapuram Swaminathan Shankar | Director |
| Ms. R Bhuvaneswari | Director |
| Mr. Thanjavur Kanakaraj Arun | Director |
| Dr. N Sundaradevan | Director |
| Mr. Govindarajan Dattatreyan Sharma | Director |
| Ms. Devaki Ashwin Muthiah | Director |
| Ms. Latha Ramanathan | Director |
| Mr. Hugo Chardon | Director |
FAQ
What is the intrinsic value of Manali Petrochemicals Ltd?
Manali Petrochemicals Ltd's intrinsic value (as of 25 January 2026) is ₹18.47 which is 65.41% lower the current market price of ₹53.40, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹918 Cr. market cap, FY2025-2026 high/low of ₹81.1/49.2, reserves of ₹1,056 Cr, and liabilities of ₹1,472 Cr.
What is the Market Cap of Manali Petrochemicals Ltd?
The Market Cap of Manali Petrochemicals Ltd is 918 Cr..
What is the current Stock Price of Manali Petrochemicals Ltd as on 25 January 2026?
The current stock price of Manali Petrochemicals Ltd as on 25 January 2026 is ₹53.4.
What is the High / Low of Manali Petrochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Manali Petrochemicals Ltd stocks is ₹81.1/49.2.
What is the Stock P/E of Manali Petrochemicals Ltd?
The Stock P/E of Manali Petrochemicals Ltd is 17.8.
What is the Book Value of Manali Petrochemicals Ltd?
The Book Value of Manali Petrochemicals Ltd is 66.4.
What is the Dividend Yield of Manali Petrochemicals Ltd?
The Dividend Yield of Manali Petrochemicals Ltd is 0.94 %.
What is the ROCE of Manali Petrochemicals Ltd?
The ROCE of Manali Petrochemicals Ltd is 4.66 %.
What is the ROE of Manali Petrochemicals Ltd?
The ROE of Manali Petrochemicals Ltd is 2.92 %.
What is the Face Value of Manali Petrochemicals Ltd?
The Face Value of Manali Petrochemicals Ltd is 5.00.